These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23763856)

  • 1. Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records.
    Phansalkar S; Desai A; Choksi A; Yoshida E; Doole J; Czochanski M; Tucker AD; Middleton B; Bell D; Bates DW
    BMC Med Inform Decis Mak; 2013 Jun; 13(1):65. PubMed ID: 23763856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-priority drug-drug interactions for use in electronic health records.
    Phansalkar S; Desai AA; Bell D; Yoshida E; Doole J; Czochanski M; Middleton B; Bates DW
    J Am Med Inform Assoc; 2012; 19(5):735-43. PubMed ID: 22539083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-priority and low-priority drug-drug interactions in different international electronic health record systems: A comparative study.
    Cornu P; Phansalkar S; Seger DL; Cho I; Pontefract S; Robertson A; Bates DW; Slight SP
    Int J Med Inform; 2018 Mar; 111():165-171. PubMed ID: 29425628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-drug interactions that should be non-interruptive in order to reduce alert fatigue in electronic health records.
    Phansalkar S; van der Sijs H; Tucker AD; Desai AA; Bell DS; Teich JM; Middleton B; Bates DW
    J Am Med Inform Assoc; 2013 May; 20(3):489-93. PubMed ID: 23011124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for selecting drug-drug interactions for clinical decision support.
    Tilson H; Hines LE; McEvoy G; Weinstein DM; Hansten PD; Matuszewski K; le Comte M; Higby-Baker S; Hanlon JT; Pezzullo L; Vieson K; Helwig AL; Huang SM; Perre A; Bates DW; Poikonen J; Wittie MA; Grizzle AJ; Brown M; Malone DC
    Am J Health Syst Pharm; 2016 Apr; 73(8):576-85. PubMed ID: 27045070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study.
    Horn J; Ueng S
    Ann Pharmacother; 2019 Nov; 53(11):1087-1092. PubMed ID: 31296026
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record.
    Wright A; Aaron S; Seger DL; Samal L; Schiff GD; Bates DW
    J Gen Intern Med; 2018 Nov; 33(11):1868-1876. PubMed ID: 29766382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Overridden Medication-related Clinical Decision Support in the Intensive Care Unit between a Commercial System and a Legacy System.
    Wong A; Wright A; Seger DL; Amato MG; Fiskio JM; Bates D
    Appl Clin Inform; 2017 Aug; 8(3):866-879. PubMed ID: 28832067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving medication-related clinical decision support.
    Tolley CL; Slight SP; Husband AK; Watson N; Bates DW
    Am J Health Syst Pharm; 2018 Feb; 75(4):239-246. PubMed ID: 29436470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Decision Support Systems for Drug Allergy Checking: Systematic Review.
    Légat L; Van Laere S; Nyssen M; Steurbaut S; Dupont AG; Cornu P
    J Med Internet Res; 2018 Sep; 20(9):e258. PubMed ID: 30194058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of medication alerts in electronic health records for compliance with human factors principles.
    Phansalkar S; Zachariah M; Seidling HM; Mendes C; Volk L; Bates DW
    J Am Med Inform Assoc; 2014 Oct; 21(e2):e332-40. PubMed ID: 24780721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structured override reasons for drug-drug interaction alerts in electronic health records.
    Wright A; McEvoy DS; Aaron S; McCoy AB; Amato MG; Kim H; Ai A; Cimino JJ; Desai BR; El-Kareh R; Galanter W; Longhurst CA; Malhotra S; Radecki RP; Samal L; Schreiber R; Shelov E; Sirajuddin AM; Sittig DF
    J Am Med Inform Assoc; 2019 Oct; 26(10):934-942. PubMed ID: 31329891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
    Payne TH; Hines LE; Chan RC; Hartman S; Kapusnik-Uner J; Russ AL; Chaffee BW; Hartman C; Tamis V; Galbreth B; Glassman PA; Phansalkar S; van der Sijs H; Gephart SM; Mann G; Strasberg HR; Grizzle AJ; Brown M; Kuperman GJ; Steiner C; Sullins A; Ryan H; Wittie MA; Malone DC
    J Am Med Inform Assoc; 2015 Nov; 22(6):1243-50. PubMed ID: 25829460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches.
    Classen DC; Phansalkar S; Bates DW
    J Patient Saf; 2011 Jun; 7(2):61-5. PubMed ID: 21577077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Late Attempt to Involve End Users in the Design of Medication-Related Alerts: Survey Study.
    Baysari MT; Zheng WY; Van Dort B; Reid-Anderson H; Gronski M; Kenny E
    J Med Internet Res; 2020 Mar; 22(3):e14855. PubMed ID: 32167479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing and evaluating contextualized drug-drug interaction algorithms.
    Chou E; Boyce RD; Balkan B; Subbian V; Romero A; Hansten PD; Horn JR; Gephart S; Malone DC
    JAMIA Open; 2021 Jan; 4(1):ooab023. PubMed ID: 33763631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.
    Page N; Baysari MT; Westbrook JI
    Int J Med Inform; 2017 Sep; 105():22-30. PubMed ID: 28750908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.